Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 154

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 2
Chunk 154
---
 and other (income) charges, net1.0 3.3 10.1 8.3 Goodwill impairment charge— — 183.8 306.6 Acquisition-related costs— (0.1)— — Other (income) expense, net1.2 6.5 9.5 7.8 Interest expense, net18.4 23.8 56.4 69.3 Income (loss) from continuing operations before income taxes62.2 54.0 (36.7)(164.6)Provision (benefit) for income taxes on continuing operations21.4 6.5 34.8 (23.6)Net income (loss) from continuing operations40.8 47.5 (71.5)(141.0)Income (loss) from discontinued operations, net of income taxes2.7 (154.7)(11.0)(305.9)Net income (loss)$43.5 $(107.2)$(82.5)$(446.9)

Q3 2025 Performance Summary

Net sales were flat to the prior year. Increased Net sales in the Performance Chemicals reportable segment's road technologies product line and Performance Materials reportable segment was offset by lower volumes in Advanced Polymer Technologies due to the indirect impact of tariffs.

Net sales

The table below shows the 2025 Net sales and variances from 2024:Change vs. prior yearIn millionsPrior year Net salesVolumePrice/MixCurrency effectCurrent year Net salesThree months ended September 30, 2025 vs. 2024$333.8 (1.4)(0.3)1.0 $333.1 Nine months ended September 30, 2025 vs. 2024$936.8 (37.3)11.9 1.1 $912.5 

Three Months Ended September 30, 2025 vs 2024

The Net sales decrease of $0.7 million in 2025 was driven by a volume decline of $1.4 million (zero percent) and unfavorable pricing and sales mix of $0.3 million (zero percent). This decline was partially offset by favorable foreign currency exchange of $1.0 million (zero percent).

Nine Months Ended September 30, 2025 vs. 2024

The Net sales decrease of $24.3